Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Vaccine|July 6, 2015
Safety and immunogenicity of a trivalent recombinant PcpA, PhtD, and PlyD1 pneumococcal protein vaccine in adults, toddlers, and infants: A phase I randomized controlled studyW Abdullah Brooks, Lee-Jah Chang, Xiaohua Sheng, et al.
Vaccine|August 22, 2019
Safety and immunogenicity of high-dose quadrivalent influenza vaccine in adults ≥65 years of age: A phase 3 randomized clinical trialLee-Jah Chang, Ya Meng, Helene Janosczyk, et al.
Vaccine|March 27, 2020
A Phase II, randomized, immunogenicity and safety study of a quadrivalent meningococcal conjugate vaccine, MenACYW-TT, in healthy adolescents in the United StatesLee-Jah Chang, James Hedrick, Shane Christensen, et al.
Human Vaccines & Immunotherapeutics|October 22, 2019
Immunogenicity and safety of high-dose quadrivalent influenza vaccine in Japanese adults ≥65 years of age: a randomized controlled clinical trialLeilani Sanchez, Osamu Matsuoka, Satoshi Inoue, et al.
Vaccine|February 21, 2021
Safety and immunogenicity of high doses of quadrivalent influenza vaccine in children 6 months through <18 years of age: A randomized controlled phase II dose-finding trialLee-Jah Chang, Evan J Anderson, Robert Jeanfreau, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2009
The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identificationTongtong Liu, Lee-Jah Chang, Annette Uss, et al.
Vaccine|March 11, 2023
Superior immunogenicity of high-dose quadrivalent inactivated influenza vaccine versus Standard-Dose vaccine in Japanese Adults ≥ 60 years of age: Results from a phase III, randomized clinical trialLeilani Sanchez, Takahiro Nakama, Hideaki Nagai, et al.
Vaccine|February 7, 2021
Introductory paper: High-dose influenza vaccineMia Diaco, Lee-Jah Chang, Bruce Seet, et al.
The Journal of Allergy and Clinical Immunology|December 4, 2012
Blockade of peanut allergy with a novel Ara h 2-Fcγ fusion protein in miceYu Liu, Yongtao Sun, Lee-Jah Chang, et al.
Clinical Pharmacokinetics|March 31, 2026
Pharmacokinetic Comparability Assessment of Tixagevimab and Cilgavimab Developed for COVID-19 Prevention and Treatment Using Standard Exposure Metrics and Partial Area Under the CurveHuixia Zhang, Weifeng Tang, Samuel Sadow, et al.
Pageof 2